Analysts showing optimistic trends for Banco Santander (Mexico), S.A., Institucion de Ban(NYSE:BSMX): Sierra Oncology, Inc.(NASDAQ:SRRA)

0
5

Banco Santander (Mexico), S.A., Institucion de Ban (BSMX) will report its next earnings on Apr 29 AMC. The company reported the earnings of $0.22/Share in the last quarter where the estimated EPS by analysts was $0.2/share. The difference between the expected and actual EPS was $0.02/share, which represents an Earnings surprise of 10%.

Many analysts are providing their Estimated Earnings analysis for Banco Santander (Mexico), S.A., Institucion de Ban and for the current quarter 3 analysts have projected that the stock could give an Average Earnings estimate of $0.21/share. These analysts have also projected a Low Estimate of $0.21/share and a High Estimate of $0.21/share.

These analysts also forecasted Growth Estimates for the Current Quarter for BSMX to be -31.8%. They are projecting Next Quarter growth of -38.1%. For the next 5 years, Banco Santander (Mexico), S.A., Institucion de Ban is expecting Growth of -3.33% per annum, whereas in the past 5 years the growth was -39.02% per annum.

Some buy side analysts are also providing their Analysis on Banco Santander (Mexico), S.A., Institucion de Ban, where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 1.53 and Average Volume (3 months) is 637.36 million. The company’s P/E (price to earnings) ratio is 14.87 and Forward P/E ratio of 5.69.

The company shows its Return on Assets (ROA) value of 0%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Banco Santander (Mexico), S.A., Institucion de Ban currently shows a Weekly Performance of 5.84%, where Monthly Performance is 13.73%, Quarterly performance is -61.84%, 6 Months performance is -55.93% and yearly performance percentage is -62.14%. Year to Date performance value (YTD perf) value is -57.23%. The Stock currently has a Weekly Volatility of 5.47% and Monthly Volatility of 6.48%.

Sierra Oncology, Inc. (SRRA) will report its next earnings on Mar 03 BMO. The company reported the earnings of $-7.88/Share in the last quarter where the estimated EPS by analysts was $-3.16/share. The difference between the expected and actual EPS was $-4.72/share, which represents an Earnings surprise of -149.4%.

Many analysts are providing their Estimated Earnings analysis for Sierra Oncology, Inc. and for the current quarter 2 analysts have projected that the stock could give an Average Earnings estimate of $-2.74/share. These analysts have also projected a Low Estimate of $-2.78/share and a High Estimate of $-2.7/share.

These analysts also forecasted Growth Estimates for the Current Quarter for SRRA to be 72.5%. They are projecting Next Quarter growth of 67.35%. For the next 5 years, Sierra Oncology, Inc. is expecting Growth of 37.67% per annum, whereas in the past 5 years the growth was 45.5% per annum.

Some buy side analysts are also providing their Analysis on Sierra Oncology, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 1.74 and Average Volume (3 months) is 23.99 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -96.4%. The Return on Equity (ROE) value stands at -124.2%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Sierra Oncology, Inc. currently shows a Weekly Performance of 16.46%, where Monthly Performance is 16.39%, Quarterly performance is -13.53%, 6 Months performance is 35% and yearly performance percentage is -76.54%. Year to Date performance value (YTD perf) value is -3.4%. The Stock currently has a Weekly Volatility of 5.69% and Monthly Volatility of 7.50%.

SHARE